AR007648A1 - Forma de dosis farmaceutica de gelatina blanda, de fases multiples - Google Patents

Forma de dosis farmaceutica de gelatina blanda, de fases multiples

Info

Publication number
AR007648A1
AR007648A1 ARP970102858A ARP970102858A AR007648A1 AR 007648 A1 AR007648 A1 AR 007648A1 AR P970102858 A ARP970102858 A AR P970102858A AR P970102858 A ARP970102858 A AR P970102858A AR 007648 A1 AR007648 A1 AR 007648A1
Authority
AR
Argentina
Prior art keywords
phases
dosage form
pharmaceutical dosage
phase
multiple phases
Prior art date
Application number
ARP970102858A
Other languages
English (en)
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Publication of AR007648A1 publication Critical patent/AR007648A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Una forma de dosis farmacéutica de gelatina blanda, de fases múltiples, que comprende: una envolvente común de material polimérico; una primer faseque comprende un primer material de relleno semisólido; una segunda fase que comprende un segundo material de relleno semisólido; y por lo menos una dedichas fases primera y segundo contiene un ingrediente activo; cada una de las fases primera y segunda está dispuesta en regiones discretas de la envolventey en contacto mutuo en al menos una interfase; difiriendo las fases primera y segunda en su composición y por lo menos una de dichas fases tiene una turbidezde menos de 1,300 UTN.
ARP970102858A 1996-06-28 1997-06-27 Forma de dosis farmaceutica de gelatina blanda, de fases multiples AR007648A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/671,979 US6024980A (en) 1996-06-28 1996-06-28 Multiphase soft gelatin dosage form

Publications (1)

Publication Number Publication Date
AR007648A1 true AR007648A1 (es) 1999-11-10

Family

ID=24696660

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970102858A AR007648A1 (es) 1996-06-28 1997-06-27 Forma de dosis farmaceutica de gelatina blanda, de fases multiples

Country Status (24)

Country Link
US (1) US6024980A (es)
EP (1) EP0815855B1 (es)
JP (1) JPH10182437A (es)
KR (1) KR980000438A (es)
CN (1) CN1172642A (es)
AR (1) AR007648A1 (es)
AT (1) ATE223707T1 (es)
AU (1) AU2620197A (es)
BR (1) BR9703771A (es)
CO (1) CO4900025A1 (es)
CZ (1) CZ205697A3 (es)
DE (1) DE69715319T2 (es)
DK (1) DK0815855T3 (es)
ES (1) ES2183089T3 (es)
HU (1) HUP9701113A2 (es)
ID (1) ID17794A (es)
IL (1) IL121145A0 (es)
NO (1) NO972963L (es)
NZ (1) NZ328182A (es)
PL (1) PL320815A1 (es)
PT (1) PT815855E (es)
SG (1) SG54525A1 (es)
TN (1) TNSN97111A1 (es)
ZA (1) ZA975767B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
EP1163901B1 (en) 1999-02-26 2008-09-10 Shionogi & Co., Ltd. Chewable soft capsules having improved administration properties and process for producing the same
US20030060422A1 (en) 2001-08-31 2003-03-27 Balaji Venkataraman Tannate compositions and methods of treatment
WO2003024421A2 (en) * 2001-09-18 2003-03-27 The North West University Triclosan dosage form
US20050182056A9 (en) * 2002-02-21 2005-08-18 Seth Pawan Modified release formulations of at least one form of tramadol
US8128957B1 (en) 2002-02-21 2012-03-06 Valeant International (Barbados) Srl Modified release compositions of at least one form of tramadol
US7670612B2 (en) 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
CA2498798A1 (en) * 2002-09-20 2004-04-01 Alpharma, Inc. Sustained-release opioid formulations and methods of use
FR2850275B1 (fr) * 2003-01-24 2005-04-08 Scherer Technologies Inc R P Capsules molles a macher contenant une substance active a gout masque
US20040185032A1 (en) * 2003-03-18 2004-09-23 David Burrell Compositions and methods for treating colic
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
US20050249802A1 (en) * 2004-05-06 2005-11-10 The Procter & Gamble Company Softgel encapsulated pharmaceutical compositions comprising concentrated active ingredients
US20070036859A1 (en) * 2005-08-11 2007-02-15 Perry Ronald L Sustained release antihistamine and decongestant composition
ES2569925T3 (es) 2009-09-30 2016-05-13 Acura Pharmaceuticals, Inc. Métodos y composiciones de disuasión del abuso
WO2013155430A1 (en) * 2012-04-13 2013-10-17 Banner Pharmacaps, Inc. Soft elastic capsules containing tablets and liquid or semisolid fills and methods for their manufacture
RU2673818C2 (ru) 2012-11-30 2018-11-30 Экьюра Фармасьютикалз, Инк. Саморегулируемое высвобождение фармацевтического ингредиента
KR20150131070A (ko) * 2013-03-15 2015-11-24 워너 칠콧 컴퍼니 엘엘씨 개질된 구아 검을 갖는 제약 연질 젤라틴 캡슐 투여 형태
US10195153B2 (en) 2013-08-12 2019-02-05 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
CA2943725C (en) 2014-03-26 2019-06-25 Sun Pharma Advanced Research Company Ltd. Abuse deterrent immediate release coated reservoir solid dosage form
CA2955229C (en) 2014-07-17 2020-03-10 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
EP3209282A4 (en) 2014-10-20 2018-05-23 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
US11103581B2 (en) 2015-08-31 2021-08-31 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient
WO2019165420A1 (en) * 2018-02-26 2019-08-29 R.P. Scherer Technologies, Llc Pharmaceutical dosage form for an emulsion of simethicone and loperamide
WO2020047205A1 (en) * 2018-08-31 2020-03-05 Arctic Therapeutics, Llc Novel topical formulation for intradermal application and uses thereof

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59131355A (ja) * 1983-01-17 1984-07-28 森下仁丹株式会社 多重軟カプセルの製法
US4486412A (en) * 1983-03-15 1984-12-04 Pharmacaps, Inc. Encapsulated antacid dispersions
EP0211079A4 (en) * 1985-01-31 1988-02-15 Fujisawa Pharmaceutical Co BENDABLE CAPSULE WITH SEVERAL CHAMBERS, METHOD AND DEVICE FOR THEIR PRODUCTION.
JPS61189230A (ja) * 1985-02-19 1986-08-22 Nippon Kayaku Co Ltd エトポシド製剤
GB8507779D0 (en) * 1985-03-26 1985-05-01 Fujisawa Pharmaceutical Co Drug carrier
US4639846A (en) * 1985-08-16 1987-01-27 Bbc Brown, Boveri & Company, Limited Method and compensating device for compensating current oscillations
US5209978A (en) * 1985-12-26 1993-05-11 Taisho Pharmaceutical Co., Ltd. Seamless soft capsule and production thereof
DE3600084A1 (de) * 1986-01-03 1987-07-09 Scherer Gmbh R P Formkoerper sowie verfahren und vorrichtung zur herstellung eines solchen formkoerpers
US4708834A (en) * 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
DE3727894A1 (de) * 1987-08-21 1989-03-02 Stephan Dieter Kapsel fuer pharmazeutisch wirksame inhaltsstoffe einer droge
FR2624012B1 (fr) * 1987-12-07 1991-05-31 Fdb Ste Civile Rech Nouvelles compositions pharmaceutiques a action hypnotique a base d'hydrate de chloral
US4956184A (en) * 1988-05-06 1990-09-11 Alcide Corporation Topical treatment of genital herpes lesions
US4935243A (en) * 1988-12-19 1990-06-19 Pharmacaps, Inc. Chewable, edible soft gelatin capsule
US5073384A (en) * 1989-10-19 1991-12-17 Valentine Enterprises, Inc. Maltodextrin/defoaming composition combinate
GB8926612D0 (en) * 1989-11-24 1990-01-17 Erba Farmitalia Pharmaceutical compositions
IE64128B1 (en) * 1990-02-26 1995-07-12 Byrne Rynne Holdings Ltd A pharmaceutical composition
GB9022788D0 (en) * 1990-10-19 1990-12-05 Cortecs Ltd Pharmaceutical formulations
GR1002332B (el) * 1992-05-21 1996-05-16 Mcneil-Ppc Inc. Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη.
US5501857A (en) * 1992-07-24 1996-03-26 Midwestern Bio-Ag Products & Services, Inc. Oral nutritional and dietary composition
EP0706380B1 (en) * 1993-06-30 2001-08-16 Fujisawa Pharmaceutical Co., Ltd. Encapsulated medicine
US5725846A (en) * 1995-03-02 1998-03-10 The Gillette Company Clear antiperspirant stick containing dibenzylidene alditol and hydroxyalkyl cellulose

Also Published As

Publication number Publication date
CZ205697A3 (cs) 1998-01-14
IL121145A0 (en) 1997-11-20
NO972963L (no) 1997-12-29
EP0815855A1 (en) 1998-01-07
EP0815855B1 (en) 2002-09-11
TNSN97111A1 (fr) 2005-03-15
ZA975767B (en) 1998-12-28
PL320815A1 (en) 1998-01-05
AU2620197A (en) 1998-01-15
US6024980A (en) 2000-02-15
HU9701113D0 (en) 1997-08-28
ATE223707T1 (de) 2002-09-15
KR980000438A (ko) 1998-03-30
HUP9701113A2 (hu) 1998-08-28
DE69715319T2 (de) 2003-01-23
SG54525A1 (en) 1998-11-16
DK0815855T3 (da) 2003-01-06
ID17794A (id) 1998-01-29
CO4900025A1 (es) 2000-03-27
ES2183089T3 (es) 2003-03-16
PT815855E (pt) 2003-01-31
CN1172642A (zh) 1998-02-11
DE69715319D1 (de) 2002-10-17
NZ328182A (en) 1998-11-25
NO972963D0 (no) 1997-06-25
BR9703771A (pt) 1998-09-01
JPH10182437A (ja) 1998-07-07
MX9704846A (es) 1998-07-31

Similar Documents

Publication Publication Date Title
AR007648A1 (es) Forma de dosis farmaceutica de gelatina blanda, de fases multiples
ATE268167T1 (de) Mehrphasige wirkstoffhaltige zubereitungsformen
BR0212951A (pt) Formas de dosagens compósitas
ES2116804T3 (es) Preparado polifasico para la anticoncepcion basado en estrogenos naturales.
ATE554750T1 (de) Hydrophobe pharmazeutische wirkstoffe enthaltende zubereitungen
ATE270544T1 (de) Halbfeste arzneizubereitung enthaltend isotretinoin
DE122010000030I2 (de) Verbindungen von wirkstoffen, welche klopidogrel und antithrombotische mittel enthalten.
ATE224717T1 (de) Oral anzuwendende arzneizubereitungen enthaltend eine benzhydrylpiperazine und eine zyklodextrin
DZ2509A1 (fr) Analogues peptidiques de la lh-rh leur utilisationet les compositions pharmaceutiques les contenant.
HUP9701111A2 (hu) Töltőanyag lágy zselatin kapszula gyógyszeradagolási formához
EP0983995A3 (de) Dimethyl-(3-aryl-but-3-enyl)-aminverbindungen als pharmazeutische Wirkstoffe
BR9906285A (pt) Manocápsulas, composição cosméticas ou dermatológica, e, processo de preparação das manocápsulas
ES2173595T3 (es) Encapsulado de ingredientes activos.
WO2001001931A3 (de) Parfümhaltiges mittel zur behandlung der haare oder der haut mit zwei phasen
TR199903211T2 (xx) Azasteroitler içeren çözeltiler.
ES2176805T3 (es) Empleo de mezclas de productos activos para la obtencion de agentes hipocolesterinemicos.
TR200100096T2 (tr) Deterjan tableti
BR9506389B1 (pt) composto de silìcio, e, composição dietética, cosmética e terapêutica.
ES2147163A1 (es) Una composicion farmaceutica con actividad reguladora de la expresion de las moleculas de adhesion.
AR007650A1 (es) Composicion farmaceutica para forma de dosis farmaceutica de gelatina blanda y forma de dosis que la comprende
NO971851D0 (no) Barnesikker forpakning for virkestoffinneholdende plaster
ATE29878T1 (de) Pharmazeutisch wirksame verbindungen und deren herstellung.
MA26447A1 (fr) Analogues peptidiques de la lh-rh, leurs utilisations et compositions pharmaceutiques en contenant
FR2663543B1 (fr) Lyophilisat de potiron doux hybride et medicaments le contenant.
DE59908258D1 (de) Blister enthaltend ein transdermales therapeutisches system und eine einzeldosierte darreichungsform